ASCLEPIX THERAPEUTICS
AsclepiX Therapeutics represents the next generation of biologics and drug development technology. They use bioinformatics and systems biology methods to design classes of short biomimetic anti-angiogenic (anti-neovascular), and anti-lymphangiogenic peptides. They also use the latest developments in biomaterials and drug delivery to design long-lasting biodegradable nano and microparticles to deliver these biomimetic therapeutic peptides throughout the body. AsclepiX Therapeutics utilizes its platform technology for indications in ophthalmology, oncology, and for other angiogenesis and lymphangiogenesis-dependent diseases.
ASCLEPIX THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Health Diagnostics Therapeutics
Founded:
2011-01-01
Address:
Baltimore, Maryland, United States
Country:
United States
Website Url:
http://www.asclepix.com
Total Employee:
11+
Status:
Active
Contact:
410-657-2627
Email Addresses:
[email protected]
Total Funding:
50 M USD
Technology used in webpage:
Domain Not Resolving Euro CrUX Top 50m CrUX Dataset
Similar Organizations
Alaya Bioscience
Alaya Bioscience is a biotech company that develops novel nanotherapeutics for the treatment of human diseases.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Perceptive Advisors
Perceptive Advisors investment in Series A - AsclepiX Therapeutics
Hibiscus Capital Management
Hibiscus Capital Management investment in Series A - AsclepiX Therapeutics
Rapha Capital Management
Rapha Capital Management investment in Series A - AsclepiX Therapeutics
Barer & Son Capital
Barer & Son Capital investment in Series A - AsclepiX Therapeutics
Perceptive Advisors
Perceptive Advisors investment in Series A - AsclepiX Therapeutics
Rapha Capital Management
Rapha Capital Management investment in Series A - AsclepiX Therapeutics
Salem Partners
Salem Partners investment in Convertible Note - AsclepiX Therapeutics
Rapha Capital Management
Rapha Capital Management investment in Convertible Note - AsclepiX Therapeutics
Piedmont Capital Partners
Piedmont Capital Partners investment in Convertible Note - AsclepiX Therapeutics
Barer & Son Capital
Barer & Son Capital investment in Convertible Note - AsclepiX Therapeutics
Official Site Inspections
http://www.asclepix.com Semrush global rank: 10.25 M Semrush visits lastest month: 240
- Host name: 228.217.209.35.bc.googleusercontent.com
- IP address: 35.209.217.228
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "AsclepiX Therapeutics"
AsclepiX Therapeutics - Crunchbase Company Profile …
Organization. AsclepiX Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. …See details»
About - AsclepiX Therapeutics
Co-founded by Aleksander S. Popel, PhD and Jordan J. Green, PhD at Johns Hopkins University, AsclepiX is building a …See details»
Contact - AsclepiX Therapeutics
Contact Us Your Name (required) Organization(required) Email Address (required) Telephone (required) Subject Your Message Contact Information Corporate Headquarters 5237 River …See details»
AsclepiX Therapeutics - LinkedIn
AsclepiX Therapeutics is a clinical-stage biopharmaceutical company leveraging computational biology from Johns Hopkins to identify and develop peptides for improved treatments of retinal …See details»
Asclepix Therapeutics, Inc. Company Profile | Baltimore, MD ...
Find company research, competitor information, contact details & financial data for Asclepix Therapeutics, Inc. of Baltimore, MD. Get the latest business insights from Dun & Bradstreet.See details»
About - AsclepiX Therapeutics
Co-founded by Aleksander S. Popel, PhD and Jordan J. Green, PhD at Johns Hopkins University, AsclepiX is building a company and culture focused on transforming the treatment of disease …See details»
AsclepiX Therapeutics Company Overview, Contact Details
Jul 26, 2023 AsclepiX Therapeutics is a clinical-stage biopharmaceutical company leveraging computational biology from Johns Hopkins to identify and develop peptides for improved …See details»
AsclepiX Therapeutics - Funding, Financials, Valuation & Investors
AsclepiX Therapeutics is a biotech company that develops novel therapeutics to revolutionize the treatment of retinal diseases and cancer. Search Crunchbase. ... How much funding has this …See details»
AsclepiX Therapeutics - VentureRadar
AsclepiX Therapeutics is a biopharmaceutical company using computational biology to identify potent peptide regulators of vascular homeostasis that is disrupted in retinal and oncologic …See details»
AsclepiX Therapeutics - Org Chart, Teams, Culture & Jobs - The Org
AsclepiX Therapeutics. Join to edit. Join to edit. AsclepiX Therapeutics is revolutionizing the treatment of retinal diseases and cancer with a singular focus on the design, development, …See details»
AsclepiX Therapeutics - Contacts, Employees, Board Members
Organization. AsclepiX Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... Contacts 6. About. AsclepiX Therapeutics …See details»
Careers - AsclepiX Therapeutics
At AsclepiX, the work is meaningful, the culture is inclusive, the company growth is rapid, and the rewards are plentiful. ... We have a competitive advantage that is enjoyed by no other …See details»
AsclepiX Therapeutics, Inc. Strengthens Board of Directors, …
Mar 25, 2019 As a Board Member, Dr. Altschuler will help AsclepiX succeed and scale as it commercializes its flagship product, AXT107, and their products for cancer. ... value-based …See details»
AsclepiX Therapeutics Raises $10M in Series A-3 Funding
Jul 26, 2023 AsclepiX Therapeutics, a Baltimore, MD-based clinical-stage biotech company leveraging computational biology to develop peptides for improved treatments of retinal …See details»
Series A - AsclepiX Therapeutics - 2023-07-26 - Crunchbase
Organization Name . AsclepiX Therapeutics . Announced Date Jul 26, 2023; Funding Type Series A; Funding Stage Early Stage Venture; Money Raised . $10M. Lead Investors. ... AsclepiX …See details»
AsclepiX secures $10 million in Series A-3 financing round - Healio
Jul 26, 2023 AsclepiX Therapeutics has secured $10 million in Series A-3 financing to advance the development of its lead clinical candidate, AXT107, for the treatment of neovascular retinal …See details»
Pipeline - AsclepiX Therapeutics
AsclepiX Therapeutics. Our Pipeline. Our lead product is AXT107, with additional follow on product candidates AXT201, AXT301 and AXT501. Our initial therapeutic focus for AXT107 is …See details»
Careers - AsclepiX Therapeutics
Ensure that RA/QA organization complies with all policies and standards. Ensure that all Corporate HR Policies and Programs are effectively implemented and respected by all …See details»
Jill Vazzano Tierney - Vice President Finance - AsclepiX ... - LinkedIn
A global, privately-held holding company with revenues of $1.6 billion that primarily engages in business process outsourcing, including, accounts receivable management, back office …See details»